Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Ricciardolo (Orbassano (To), Italy). Late Breaking Abstract - Role of Muscarinic M3 receptors in bronchial remodelling of severe asthma. 1360

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Effect of timapiprant, a DP2 antagonist, on airway inflammation in severe eosinophilic asthma Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Asthma Year: 2019 Cholinergic muscarinic receptors and airway remodelling in severe asthma Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Role of muscarinic receptors in airway inflammation and remodelling Source: International Congress 2015 – Respiratory research in the Netherlands Year: 2015 The muscarinic M3 receptor regulates allergen-induced airway remodeling in mice Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 Late Breaking Abstract - Airway sensory innervation is increased in chronic cough Source: International Congress 2018 – Notable Studies in Asthma Year: 2018 Late Breaking Abstract - Calcium-sensing receptor activators increased in the sputum of idiopathic pulmonary fibrosis patients Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Late Breaking Abstract - Role of ß-catenin and Notch signalling in increased airway mucous cell differentiation in asthma Source: International Congress 2019 – Molecular and experimental paediatric lung disease Year: 2019 Late Breaking Abstract - Airway hyperresponsiveness in bronchiectasis Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections Year: 2019 Expression of CysLT2 receptors in asthmatic lung, and the roles in bronchoconstriction Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Late Breaking Abstract - Sex differences in ß2 adrenoceptor-mediated responses in mouse airways Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 Late Breaking Abstract - Transient Receptor Potential Vanilloid subtype 4 in patients with lung cancer Source: Virtual Congress 2020 – Biological aspects of lung cancer Year: 2020 Muscarinic M3 receptors on structural cells regulate neutrophilic inflammation in mice Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 Role of the acetylcholine in the virus-induced bronchoconstriction Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 Late Breaking Abstract - IL-36 receptor agonists contribute to a pro-inflammatory milieu in smokers with and without COPD Source: International Congress 2017 – New immune markers for asthma and COPD Year: 2017 Late Breaking Abstract - Aerobic exercise reduces asthma phenotype by inhibiting purinergic signaling and lymphatic organs hyperactivation Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Late Breaking Abstract - Bronchial Thermoplasty restores constitutive high PRMT1 expression in asthmatic airways Source: International Congress 2017 – Notable abstracts in asthma Year: 2017 Late Breaking Abstract - Activation of a murine skeletal muscle M3 muscarinic Designer Receptor Exclusively Activated by Designer Drug (DREADD) has cardiopulmonary consequences Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019 LATE-BREAKING ABSTRACT: A novel role for CCR3 in promoting airways hyperreactivity; Role for CCR3-muscarinic M3 receptor heterodimers Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment Year: 2015 Late Breaking Abstract - Gender and asthma: Gender-dependent effects of obesity on allergic pulmonary inflammation Source: International Congress 2018 – Notable Studies in Asthma Year: 2018 Late Breaking Abstract - An assessment of potential predictive biomarkers for the treatment of severe eosinophilic asthma with CRTH2 antagonists Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019